Barbro Dahlén

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick Shaw, Ana R. Sousa, Stephen J. Fowler et al. · European Respiratory Journal · 2015 · 561 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4.

Sven‐Erik Dahlén, Göran K. Hansson, Per Hedqvist et al. · Proceedings of the National Academy of Sciences · 1983 · 421 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics

Barbro Dahlén, Ewa Niżankowska, A Szczeklik et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 395 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist: A Randomized, Double-Blind, Placebo-Controlled Trial

Sven‐Erik Dahlén, Kerstin Malmström, Ewa Niżankowska et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 317 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Combined Antagonism of Leukotrienes and Histamine Produces Predominant Inhibition of Allergen-Induced Early and Late Phase Airway Obstruction in Asthmatics

A. Roquet, Barbro Dahlén, Maria Kumlin et al. · American Journal of Respiratory and Critical Care Medicine · 1997 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +14